1. Akgul E, Onan HB, Bilgin SS, Tahta A, Khanmammadov E, Gungoren FZ, et al. Flow diverter stents in the treatment of cerebral aneurysms less than 5 mm. Turk Neurosurg. 2021 31(1):31-7.
2. Badnjević A, Pokvić LG, Deumić A, Bećirović LS. Postmarket surveillance of medical devices: a review. Technol Health Care. 2022 30(6):1315-29.
3. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA. 1999 Mar;281(9):824-9.
4. Chalouhi N, Jabbour P, Singhal S, Drueding R, Starke RM, Dalyai RT, et al. Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke. 2013 May;44(5):1348-53.
7. Chiu AH, Nadarajah M, Wenderoth JD. Cost analysis of intracranial aneurysmal repair by endovascular coiling versus flow diversion: at what size should we use which method? JMed Imaging Radiat Oncol. 2013 Aug;57(4):423-6.
8. Cottier JP, Pasco A, Gallas S, Gabrillargues J, Cognard C, Drouineau J, et al. Utility of balloon-assisted Guglielmi detachable coiling in the treatment of 49 cerebral aneurysms: a retrospective, multicenter study. AJNR Am J Neuroradiol. 2001 22(2):345-51.
11. Ev3 Inc. Instructions for use (IFU) pipeline embolization device. 2011. Apr;p. DRAFT IFU-0010.
15. Gurtcheff SE. Introduction to the MAUDE database. Clin Obstet Gynecol. 2008 Mar;51(1):120-3.
16. Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007 Jul;4(7):892-6.
18. Kavanagh KT, Brown RE Jr, Kraman SS, Calderon LE, Kavanagh SP. Reporter’s occupation and source of adverse device event reports contained in the FDA’s MAUDE database. Patient Relat Outcome Meas. 2019 Jul;10:205-8.
20. Normand SLT, Hatfield L, Drozda J, Resnic FS. Postmarket surveillance for medical devices: America’s new strategy. BMJ. 2012 Oct;345:e6864.
23. Pressman E, de La Garza CA, Chin F, Fishbein J, Waqas M, Siddiqui A, et al. Nuisance bleeding complications in patients with cerebral aneurysm treated with Pipeline embolization device. J Neurointerv Surg. 2021 Mar;13(3):247-50.
26. Wali AR, Park CC, Santiago-Dieppa DR, Vaida F, Murphy JD, Khalessi AA. Pipeline embolization device versus coiling for the treatment of large and giant unruptured intracranial aneurysms: a cost-effectiveness analysis. Neurosurg Focus. 2017 Jun;42(6):e6.
27. Yu SCH, Kwok CK, Cheng PW, Chan KY, Lau SS, Lui WM, et al. Intracranial aneurysms: midterm outcome of pipeline embolization device - a prospective study in 143 patients with 178 aneurysms. Radiology. 2012 Dec;265(3):893-901.
28. Zhou G, Su M, Yin YL, Li MH. Complications associated with the use of flow-diverting devices for cerebral aneurysms: a systematic review and meta-analysis. Neurosurg Focus. 2017 Jun;42(6):e17.